세포 증식 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 세포 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Cell Expansion Market Size, Share & Trends Analysis Report By Product (Instruments, Culture Flasks & Accessories, Consumables), By Cell Type (Mammalian, Microbial), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

US $ 5,950 ￦ 8,287,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,679,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,465,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

세포 증식 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 세포 증식 시장 규모는 2030년까지 471억 3,000만 달러에 달하고 CAGR은 12.85%에 달할 것으로 예상됩니다.

세포 확대 기술은 1회 탯줄 채혈로 세포치료제와 유전자 치료제를 개발하기 위해 점점 더 많이 채택되고 있습니다. 이러한 기술은 암 치료제 개발을 위해 보존된 줄기세포(SC)를 확대하는 데에도 사용할 수 있습니다. 따라서 제대혈 SCs 확대 기술의 현저한 개척은 시장 성장을 촉진할 것으로 예상됩니다.

기업들은 조직공학 제품 확대와 생물학적 제제 개발을 위해 많은 투자를 하고 있습니다. 예를 들어, 2019년 3월 Merck KGaA는 스위스의 생물학적 제제 제조 시설 확장을 위해 1억 6,800만 달러를 투자했습니다. 이러한 노력은 생물학적 제제 개발에 필요한 솔루션에 대한 수요를 증가시켜 시장 성장으로 이어질 것으로 예상됩니다.

바이오리액터는 이 시장의 기본 도구입니다. 바이오리액터 엔지니어링 접근법의 적용에 대한 광범위한 조사 연구는 새로운 배양 기술의 도입으로 이어지고 있습니다. 또한, 자동 바이오리액터와 마이크로 캐리어 기술의 조합은 암 SC의 효율적인 증식과 농축을 가능하게 합니다. 그 결과, 이러한 접근 방식은 이 시장에서 큰 지지를 받고 있습니다.

세포 증식 시장 보고서 하이라이트

• 자동 세포 증식 시스템의 광범위한 포트폴리오와 대규모 생물 생산을 위한 바이오리액터 설계의 개선은 장비에 유리한 성장 기회를 제공합니다.
• 미생물 세포 분야는 높은 처리량 배양 방식과 바이오필름 형성을 방지하는 기술 도입으로 가장 빠른 성장률을 보일 것으로 예상됩니다.
• 바이오의약품 분야는 바이오시밀러 수요 증가, 바이오 제조에 대한 지속적인 R&D 투자, 생물학적 제제 승인 건수 증가로 인해 2022년 가장 큰 매출 점유율을 차지했습니다.
• 2023년부터 2030년까지 아시아태평양은 생물 의학 산업 발전 분야에 초점을 맞춘 여러 컨소시엄의 존재로 인해 가장 빠른 CAGR을 기록할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세포 증식 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 보급과 성장 전망 매핑
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 세포 증식 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 세포 증식 시장 : 제품 추정·동향 분석

• 세포 증식 시장 : 중요한 포인트
• 세포 증식 시장 : 제품 동향과 시장 점유율 분석, 2022년 및 2030년
• 소모품
• 배양용 플라스크와 액세서리
• 기기

제5장 세포 증식 시장 : 세포 유형 추정·동향 분석

• 세포 증식 시장 : 중요한 포인트
• 세포 증식 시장 : 세포 유형 동향과 시장 점유율 분석, 2022년 및 2030년
• 포유류 세포
• 미생물 세포
• 기타

제6장 세포 증식 시장 : 용도 추정·동향 분석

• 세포 증식 시장 : 중요한 포인트
• 세포 증식 시장 : 용도 동향과 시장 점유율 분석, 2022년 및 2030년
• 바이오의약품
• 조직배양과 공학
• 백신 제조
• Drug Discovery
• 유전자 치료
• 암 조사
• 줄기세포 조사
• 기타 용도

제7장 세포 증식 시장 : 최종 용도 추정·동향 분석

• 세포 증식 시장 : 중요한 포인트
• 세포 증식 시장 : 최종 용도 동향과 시장 점유율 분석, 2022년 및 2030년
• 바이오테크놀러지 및 바이오의약품 기업
• 연구기관
• 세포은행
• 기타

제8장 세포 증식 시장 : 지역 추정·동향 분석

• 지역별 전망
• 지역별 세포 증식 시장 : 마켓플레이스에서의 중요한 포인트
• 북미
  • 시장 추정과 예측, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 상황

• 주요 시장 진출 기업에 의한 최근의 동향과 영향 분석
• 회사/경쟁 분류
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Corning Incorporated
  • Merck KGaA
  • Miltenyi Biotec
  • BD(Becton, Dickinson and Company)
  • TERUMO BCT, INC.
  • Sartorius AG
  • Takara Bio Inc.
  • TRINOVA BIOCHEM GmbH
  • upcyte technologies GmbH

ksm

영문 목차

영문목차

Cell Expansion Market Growth & Trends:

The global cell expansion market size is expected to reach USD 47.13 billion by 2030 registering a CAGR of 12.85%, according to a new report by Grand View Research, Inc.. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies. Therefore, significant developments in cord blood SCs expansion technologies are expected to boost market growth.

Companies have made heavy investments for the expansion of tissue-engineered products and the development of biologics. For instance, in March 2019, Merck KGaA invested USD 168 million for the expansion of its biologics manufacturing facility in Switzerland. Such initiatives are expected to boost the demand for solutions required for biologic development, thereby leading to market growth.

Bioreactors are fundamental tools in this market. Extensive research studies related to the applications of bioreactor engineering approaches have led to the incorporation of novel culture technologies. Moreover, the combined use of automated bioreactors with the microcarrier technology leads to an efficient expansion and enrichment of the cancer SCs. As a result, these approaches have gained immense traction in this market.

Cell Expansion Market Report Highlights:

• Broad portfolio of automated expansion systems along with improvements in bioreactor design for large-scale bioproduction results in the lucrative growth opportunity for instruments
• The microbial cells segment is expected to witness the fastest growth rate owing to the implementation of high-throughput cultivation approaches and techniques that avoid the formation of biofilms
• Biopharmaceuticals segment held the largest revenue share in 2022 due to growth in the demand for biosimilars, continuous R&D investments in biomanufacturing, and rise in the number of approvals for biologics
• Asia Pacific is expected to witness the fastest CAGR from 2023 to 2030 due to presence of several consortiums that focus on the evolving fields in the biomedical industry

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Cell type
  • 1.1.3. Application
  • 1.1.4. End use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product
  • 2.2.2. Cell Type outlook
  • 2.2.3. Application outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Cell Expansion Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Cell Expansion Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Cell Expansion Market: Product Estimates & Trend Analysis

• 4.1. Cell Expansion Market: Key Takeaways
• 4.2. Cell Expansion Market: Product Movement & Market Share Analysis, 2022 & 2030
• 4.3. Consumables
  • 4.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.2. Reagents, media & serum
    • 4.3.2.1. Reagents, media & serum market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.3. Other consumables
    • 4.3.3.1. Other consumables market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Cultural flasks and accessories
  • 4.4.1. Cultural flasks and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Tissue culture flasks
    • 4.4.2.1. Tissue culture flasks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Bioreactor accessories
    • 4.4.3.1. Bioreactor accessories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Other culture flasks and accessories
    • 4.4.4.1. Other culture flasks and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.2. Automated cell expansion systems
    • 4.5.2.1. Automated cell expansion systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.3. Cell counters
    • 4.5.3.1. Cell counters market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.4. Centrifuges
    • 4.5.4.1. Centrifuges market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.5. Bioreactors
    • 4.5.5.1. Bioreactors market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5.6. Other instruments
    • 4.5.6.1. Other instruments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell Expansion Market: Cell Type Estimates & Trend Analysis

• 5.1. Cell Expansion Market: Key Takeaways
• 5.2. Cell Expansion Market: Cell Type Movement & Market Share Analysis, 2022 & 2030
• 5.3. Mammalian cells
  • 5.3.1. Mammalian cells market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.2. Human cells
    • 5.3.2.1. Human cells market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2.2. Stem cells
    • 5.3.2.2.1. Stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2.2.2. Adult stem cells
    • 5.3.2.2.2.1. Adult cells market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2.2.3. Induced pluripotent stem cells
    • 5.3.2.2.3.1. Induced pluripotent stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2.2.4. Embryonic stem cells
    • 5.3.2.2.4.1. Embryonic stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2.3. Differentiated cells
    • 5.3.2.3.1. Differentiated cells market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.3. Animal cells
    • 5.3.3.1. Animal cells market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Microbial cells
  • 5.4.1. Microbial cells market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Other cell types market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell Expansion Market: Application Estimates & Trend Analysis

• 6.1. Cell Expansion Market: Key Takeaways
• 6.2. Cell Expansion Market: Application Movement & Market Share Analysis, 2022 & 2030
• 6.3. Biopharmaceuticals
  • 6.3.1. Biopharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Tissue culture & engineering
  • 6.4.1. Tissue culture & engineering market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Vaccine production
  • 6.5.1. Vaccine production market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Drug development
  • 6.6.1. Drug development market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Gene therapy
  • 6.7.1. Gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.8. Cancer research
  • 6.8.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.9. Stem cell research
  • 6.9.1. Stem cell research market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.10. Other applications
  • 6.10.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cell Expansion Market: End Use Estimates & Trend Analysis

• 7.1. Cell Expansion Market: Key Takeaways
• 7.2. Cell Expansion Market: End-use Movement & Market Share Analysis, 2022 & 2030
• 7.3. Biotechnology & biopharmaceutical companies
  • 7.3.1. Biotechnology & biopharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.4. Research institutes
  • 7.4.1. Research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Cell banks
  • 7.5.1. Cell banks market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Cell Expansion Market: Regional Estimates & Trend Analysis

• 8.1. Regional Outlook
• 8.2. Cell Expansion Market by Region: Key Marketplace Takeaways
• 8.3. North America
  • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.3. France
    • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.6. Denmark
    • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.8. Norway
    • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.2. China
    • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.3. India
    • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.5. Thailand
    • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.6. South Korea
    • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.2. Mexico
    • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Thermo Fisher Scientific, Inc.
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. GE Healthcare
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Corning Incorporated
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Merck KGaA
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Miltenyi Biotec
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. BD (Becton, Dickinson and Company)
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. TERUMO BCT, INC.
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Sartorius AG
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Takara Bio Inc.
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. TRINOVA BIOCHEM GmbH
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. upcyte technologies GmbH
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives

관련자료